NASDAQ · STOCK
Biogen
$200.13
63/100
—
—
—
Price History (6M)
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Executive Summary
5 analysts weighed in with 60% agreement on a bullish lean. Value Analyst: Price-to-book of 1.4x is a discount to asset value. Overall recommendation: BUY.
Executive Summary
5 analysts weighed in with 60% agreement on a bullish lean. Value Analyst: Price-to-book of 1.4x is a discount to asset value. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
- Daily trend: uptrend.
- Daily uptrend conflicts with weekly downtrend — buying against the higher timeframe trend is higher risk.
- Higher Highs / Higher Lows structure confirms bullish price action.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- MACD histogram is negative (-0.435) — bearish momentum.
- Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
- Bearish candlestick pattern(s) detected: Three Black Crows.
- Risk/reward is unfavorable: 1.7% downside vs 1.0% upside.
AI Investment Committee
Committee Consensus
As of July 07, 2026
Overall Committee Score
63/100
Agreement
80%
Analysts
5
Conviction
Contested
Value Analyst
bullish
70
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ Price-to-book of 1.4x is a discount to asset value
Growth Analyst
neutral
56
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− EPS declining -8.1% YoY despite any revenue growth
Technical Analyst
neutral
54
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Technical Analysis
RSI (14)
40.5
Neutral
MACD Histogram
-0.435
Bearish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Hh Hl
Support
$197.00
Resistance
$202.35
Bollinger %B
0.39
Inside Bands
Price vs Moving Averages
EMA 9
$206.90
Below
EMA 21
$203.88
Below
EMA 50
$197.95
Above
EMA 200
$180.83
Above
Fundamental Analysis
Valuation
P/E Ratio
—
P/B Ratio
—
PEG Ratio
—
Dividend Yield
—
52W High
—
52W Low
—
Quality & Growth
ROE
—
ROA
—
Gross Margin
—
Operating Margin
—
Revenue Growth YoY
—
Debt / Equity
—
Key Risks
- MACD histogram is negative (-0.435) — bearish momentum.
- Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
- Bearish candlestick pattern(s) detected: Three Black Crows.
- Risk/reward is unfavorable: 1.7% downside vs 1.0% upside.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full BIIB Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile